 Todos Medical Ltd. OTCQB:TOMDF has announced biomarker data from its majority-owned joint venture 3CL Pharma Ltds Phase 2 clinical trial of Tollovir in hospitalized COVID-19 patients, along with plans to expand its patient sample size. 